The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. * Iran's infiltration of a Navy computer network was far more extensive than previously thought, according to officials, and the officer who led the response will likely face questions about it from senators weighing his nomination as the next head of the embattled National Security Agency. ()* Actavis Plc is in advanced talks to acquire rival drug maker Forest Laboratories Inc in a deal that could value Forest at up to $25 billion, according to people familiar with the matter.()
Shares of ACT traded higher by 0.13% or $0.25/share to $191.88. In the past year, the shares have traded as low as $82.02 and as high as $193.21. On average, 1360750 shares of ACT exchange hands on a given day and today's volume is recorded at 763671.
Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. Shares of FRX traded higher by 1.49% or $1.05/share to $71.39. In the past year, the shares have traded as low as $35.22 and as high as $72.40. On average, 2216920 shares of FRX exchange hands on a given day and today's volume is recorded at 2690634.
Source
